Feasibility of Sentinel Lymph Node Biopsy in Breast Cancer Patients with Axillary Conversion after Neoadjuvant Chemotherapy—A Single-Tertiary Centre Experience and Review of the Literature

Feasibility of Sentinel Lymph Node Biopsy in Breast Cancer Patients with Axillary Conversion after Neoadjuvant Chemotherapy—A Single-Tertiary Centre Experience and Review of the Literature

(1) Introduction: Sentinel lymph node biopsy (SLNB) is widely used in breast cancer patients who undergo neoadjuvant chemotherapy (NAC), replacing axillary lymph node dissection. While commonly accepted for cN0 patients, its role in cN1/2 patients remains controversial. Our study aims to investigate...

Full description

Bibliographic Details
Main Authors: Alexandra Maria Lazar, Mario-Demian Mutuleanu, Paula Monica Spiridon, Cristian Ioan Bordea, Tatiana Lucia Suta, Alexandru Blidaru, Mirela Gherghe
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Diagnostics
Subjects:
lymphoscintigraphy
sentinel lymph node biopsy
breast cancer
neoadjuvant chemotherapy
Online Access:https://www.mdpi.com/2075-4418/13/18/3000

Internet

https://www.mdpi.com/2075-4418/13/18/3000

Similar Items